Africa has the world’s highest rate of communicable diseases. But a lack of good data on gender-specific mortality means “conclusions may rest on shaky foundations,” leading to weaker policies and programs, write Anne-Marie Hilsdon and Zachary Donnenfeld.

Editor’s Note: This week we will highlight 5 takes on how can we reduce drug prices while preserving robust research and development, from the fall issue of Hopkins Bloomberg Public Health Magazine. Read the complete set here.

Decades after the Iran-Iraq war, Iran provides rare testing grounds for the long-term impact of chemical attacks that killed 5000 Iranians and sickened more than 100,000, according to Iran's Foundation of Martyrs and Veterans Affairs.A dozen research centers in Iran are…

Staggering global health problems need scientists who can be leaders in linking research and policy. To succeed, researchers Mandë Holford and Tolu Oni believe there are 5 skills that new scientists need.

In Africa, the risk of dying from scheduled surgery is more than double the global average, reports a new study in The Lancet—considered a deep dive into a little-studied issue.

An experimental gene therapy could change the lives of those living with hemophilia A, an incredibly high-maintenance bleeding disorder that requires frequent injections.

40 years on, the survivors of the first-ever recorded Ebola outbreak still have immunity to the virus, found a study out today in the Journal of Infectious Diseases.

During the Ebola crisis diagnosis could take up to 5 days; mobile labs sped up the process, but were still cumbersome, scuppering progress against the outbreak.Now FieldLab, a briefcase-sized testing kit set to hit the market in 2018, is helping make testing truly portable…

Confirming an association between congenital Zika virus and a spike in microcephaly cases in Brazilian babies in 2015, a new study published in The Lancet points to an absence of evidence to support other theories that cropped up.

A line-up of multidisciplinary scientists have 4 years and a $10 million Department of Defense grant to find an oceanic opioid alternative.